
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
UVSSA CRISPR/Cas9 KO Plasmid (h) | sc-408933 | 20 µg | $397.00 |
UVSSA (UV-stimulated scaffold protein A) is a key factor in transcription-coupled nucleotide excision repair (TC-NER), where it helps restore transcription after RNA polymerase II stalls at UV-induced DNA lesions. The human UVSSA protein cooperates with CSA/ERCC8 and CSB/ERCC6 and promotes recruitment and stabilization of the USP7 deubiquitinase, supporting regulated ubiquitination dynamics during repair complex assembly. Through these activities, UVSSA contributes to genome integrity, recovery of transcription following genotoxic stress, and cellular responses to UV irradiation. Defects in UVSSA-mediated TC-NER are linked to UV sensitivity and disorders within the Cockayne syndrome spectrum, making it relevant for studying DNA repair pathway dysfunction and stress-induced transcriptional failure.
UVSSA CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the UVSSA gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the UVSSA together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the UVSSA open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish UVSSA protein expression.
This CRISPR knockout system enables efficient generation of UVSSA-deficient cell models for investigation of UVSSA signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.